BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 36652220)

  • 1. The ups and downs of STAT3 function: too much, too little and human immune dysregulation.
    Mackie J; Ma CS; Tangye SG; Guerin A
    Clin Exp Immunol; 2023 Apr; 212(2):107-116. PubMed ID: 36652220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
    Leiding JW; Vogel TP; Santarlas VGJ; Mhaskar R; Smith MR; Carisey A; Vargas-Hernández A; Silva-Carmona M; Heeg M; Rensing-Ehl A; Neven B; Hadjadj J; Hambleton S; Ronan Leahy T; Meesilpavikai K; Cunningham-Rundles C; Dutmer CM; Sharapova SO; Taskinen M; Chua I; Hague R; Klemann C; Kostyuchenko L; Morio T; Thatayatikom A; Ozen A; Scherbina A; Bauer CS; Flanagan SE; Gambineri E; Giovannini-Chami L; Heimall J; Sullivan KE; Allenspach E; Romberg N; Deane SG; Prince BT; Rose MJ; Bohnsack J; Mousallem T; Jesudas R; Santos Vilela MMD; O'Sullivan M; Pachlopnik Schmid J; Průhová Š; Klocperk A; Rees M; Su H; Bahna S; Baris S; Bartnikas LM; Chang Berger A; Briggs TA; Brothers S; Bundy V; Chan AY; Chandrakasan S; Christiansen M; Cole T; Cook MC; Desai MM; Fischer U; Fulcher DA; Gallo S; Gauthier A; Gennery AR; Gonçalo Marques J; Gottrand F; Grimbacher B; Grunebaum E; Haapaniemi E; Hämäläinen S; Heiskanen K; Heiskanen-Kosma T; Hoffman HM; Gonzalez-Granado LI; Guerrerio AL; Kainulainen L; Kumar A; Lawrence MG; Levin C; Martelius T; Neth O; Olbrich P; Palma A; Patel NC; Pozos T; Preece K; Lugo Reyes SO; Russell MA; Schejter Y; Seroogy C; Sinclair J; Skevofilax E; Suan D; Suez D; Szabolcs P; Velasco H; Warnatz K; Walkovich K; Worth A; ; Seppänen MRJ; Torgerson TR; Sogkas G; Ehl S; Tangye SG; Cooper MA; Milner JD; Forbes Satter LR
    J Allergy Clin Immunol; 2023 Apr; 151(4):1081-1095. PubMed ID: 36228738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype.
    Faletti L; Ehl S; Heeg M
    Biomed J; 2021 Aug; 44(4):412-421. PubMed ID: 34366294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.
    Milner JD; Vogel TP; Forbes L; Ma CA; Stray-Pedersen A; Niemela JE; Lyons JJ; Engelhardt KR; Zhang Y; Topcagic N; Roberson ED; Matthews H; Verbsky JW; Dasu T; Vargas-Hernandez A; Varghese N; McClain KL; Karam LB; Nahmod K; Makedonas G; Mace EM; Sorte HS; Perminow G; Rao VK; O'Connell MP; Price S; Su HC; Butrick M; McElwee J; Hughes JD; Willet J; Swan D; Xu Y; Santibanez-Koref M; Slowik V; Dinwiddie DL; Ciaccio CE; Saunders CJ; Septer S; Kingsmore SF; White AJ; Cant AJ; Hambleton S; Cooper MA
    Blood; 2015 Jan; 125(4):591-9. PubMed ID: 25359994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ying and Yang of STAT3 in Human Disease.
    Vogel TP; Milner JD; Cooper MA
    J Clin Immunol; 2015 Oct; 35(7):615-23. PubMed ID: 26280891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel gain-of-function STAT3 variant in infantile-onset diabetes associated with multiorgan autoimmunity.
    Zhou Q; Chen D; Yu J; Zheng B; Zhou W; Jia Z; Zhang A; Gu W
    Mol Genet Genomic Med; 2024 Feb; 12(2):e2407. PubMed ID: 38404237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducer and activator of transcription 3: a year in review.
    Forbes LR; Milner J; Haddad E
    Curr Opin Hematol; 2016 Jan; 23(1):23-7. PubMed ID: 26574998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 signaling in immunity.
    Hillmer EJ; Zhang H; Li HS; Watowich SS
    Cytokine Growth Factor Rev; 2016 Oct; 31():1-15. PubMed ID: 27185365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT1 and STAT3 mutations: important lessons for clinical immunologists.
    Olbrich P; Freeman AF
    Expert Rev Clin Immunol; 2018 Dec; 14(12):1029-1041. PubMed ID: 30280610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal Transducer and Activator of Transcription 3 Control of Human T and B Cell Responses.
    Deenick EK; Pelham SJ; Kane A; Ma CS
    Front Immunol; 2018; 9():168. PubMed ID: 29472924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review.
    Fabre A; Marchal S; Barlogis V; Mari B; Barbry P; Rohrlich PS; Forbes LR; Vogel TP; Giovannini-Chami L
    J Allergy Clin Immunol Pract; 2019; 7(6):1958-1969.e9. PubMed ID: 30825606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3-confusion-of-function: Beyond the loss and gain dualism.
    Lodi L; Faletti LE; Maccari ME; Consonni F; Groß M; Pagnini I; Ricci S; Heeg M; Simonini G; Azzari C; Ehl S
    J Allergy Clin Immunol; 2022 Nov; 150(5):1237-1241.e3. PubMed ID: 35750105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset, fatal interstitial lung disease in STAT3 gain-of-function patients.
    Gothe F; Gehrig J; Rapp CK; Knoflach K; Reu-Hofer S; Länger F; Schramm D; Ley-Zaporozhan J; Ehl S; Schwerk N; Faletti L; Griese M
    Pediatr Pulmonol; 2021 Dec; 56(12):3934-3941. PubMed ID: 34549903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3.
    Tanita K; Sakura F; Nambu R; Tsumura M; Imanaka Y; Ohnishi H; Kato Z; Pan J; Hoshino A; Suzuki K; Yasutomi M; Umetsu S; Okada C; Takagi M; Imai K; Ohara O; Muise AM; Okada S; Morio T; Kanegane H
    J Clin Immunol; 2021 May; 41(4):780-790. PubMed ID: 33501615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The link between rheumatic disorders and inborn errors of immunity.
    Sogkas G; Witte T
    EBioMedicine; 2023 Apr; 90():104501. PubMed ID: 36870198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating mutations of STAT3: Impact on human growth.
    Gutiérrez M
    Mol Cell Endocrinol; 2020 Dec; 518():110979. PubMed ID: 32818584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation.
    Wienke J; Janssen W; Scholman R; Spits H; van Gijn M; Boes M; van Montfrans J; Moes N; de Roock S
    Oncotarget; 2015 Aug; 6(24):20037-42. PubMed ID: 26343524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 gain-of-function mutation in an adult patient.
    López AL; Niemela J; Stoddard J; Paolini MV; Rosenzweig S; Fernández Romero DS
    Medicina (B Aires); 2021; 81(6):1065-1068. PubMed ID: 34875609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of STAT3 in leading the crosstalk between human cancers and the immune system.
    Wang Y; Shen Y; Wang S; Shen Q; Zhou X
    Cancer Lett; 2018 Feb; 415():117-128. PubMed ID: 29222039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T
    Zhang Y; Siegel AM; Sun G; Dimaggio T; Freeman AF; Milner JD
    J Allergy Clin Immunol; 2019 Mar; 143(3):1108-1118.e4. PubMed ID: 30030006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.